Login
From:
U.S. Food and Drug Administration
(Uncensored)
subscribe
FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval | FDA
https://www.fda.gov/news-events/press-announcements/fda-converts-novel-alzheimers-disease-treatment-traditional-approval
links
backlinks
The FDA converted Leqembi (lecanemab-irmb), indicated to treat adult patients with Alzheimer’s Disease, to traditional approval.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
